Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
Lucie Bartova, Markus Dold, Hans‐Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 1, pp. 51-63
Open Access | Times Cited: 12

Showing 12 citing articles:

Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials
Markus Dold, Hans‐Jürgen Möller, Hans‐Peter Volz, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 4
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial
Siegfried Kasper, Hans‐Peter Volz, Hans‐Jürgen Möller, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Markus Dold, Lucie Bartova, Hans‐Peter Volz, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1615-1628
Open Access | Times Cited: 10
The clinical perspective on late-onset depression in European real-world treatment settings
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology (2024) Vol. 84, pp. 59-68
Open Access | Times Cited: 2
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data
Siegfried Kasper, Anne Eckert
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 2
Silexan for treatment of anxiety and depression in the context of COVID-19
Lucie Bartova, Markus Dold, Gernot Fugger, et al.
European Neuropsychopharmacology (2023) Vol. 70, pp. 47-48
Open Access | Times Cited: 5
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan
Siegfried Kasper, Anne Eckert, Hans‐Jürgen Möller, et al.
International Journal of Psychiatry in Clinical Practice (2023) Vol. 27, Iss. 3, pp. 285-291
Open Access | Times Cited: 5
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 105-114
Open Access | Times Cited: 2
Prescription of Silexan Is Associated with Less Frequent General Practitioner Repeat Consultations Due to Disturbed Sleep Compared to Benzodiazepine Receptor Agonists: A Retrospective Database Analysis
Tillmann H. C. Krüger, Eva‐Maria Becker, Karel Kostev
Healthcare (2022) Vol. 11, Iss. 1, pp. 77-77
Open Access | Times Cited: 3
How to treat subsyndromal anxiety disorder – practical recommendations for implementation in primary care
Daniel L. Costa, Rodolfo Furlan Damiano, J.Á. Cuesta Alcalá, et al.
International Journal of Psychiatry in Clinical Practice (2024), pp. 1-10
Closed Access
Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und Depression
Jan Zourek, Rainer Stange, Siegfried Kasper, et al.
Zeitschrift für Phytotherapie (2024) Vol. 45, Iss. 04, pp. 148-156
Closed Access
Page 1

Scroll to top